- Gathering information from market participants
- Investigation in early stages
- Working with several other agencies
Emailed statement to Bloomers
Emailed statement to Bloomers
Most Popular
Sponsored
Paramount's stock drops 33% on weak revenue growth & negative FCF outlook. Valuation's fair, but risks loom.
Snap's 8.8% revenue growth lags Meta's 19.9% CAGR. Unprofitable, it faces tough competition.
PLUG rallies 21% on strong Q1 sales & guidance. Analysts hike targets, seeing 32% upside.
FTI Consulting beats revenue estimates but misses EPS; stock down 19.2%. CBIZ raises guidance, stock down 13.6%.
MAZE up 180% YOY, but fund trims $3.1M stake post-Phase 2 data. Valuation high, risks loom.
RKT surges 118% on revenue beat, but market shrugs. LADR, FBRT, FLG miss estimates, stocks flat to down.
TYRA's 280% surge continues as HighVista adds shares. Preclinical biotech, no revenue, but strong cash runway.
Sponsored
Must Read